DE60325382D1 - Verfahren zur diagnose von gebärmutterhalskrebs - Google Patents

Verfahren zur diagnose von gebärmutterhalskrebs

Info

Publication number
DE60325382D1
DE60325382D1 DE60325382T DE60325382T DE60325382D1 DE 60325382 D1 DE60325382 D1 DE 60325382D1 DE 60325382 T DE60325382 T DE 60325382T DE 60325382 T DE60325382 T DE 60325382T DE 60325382 D1 DE60325382 D1 DE 60325382D1
Authority
DE
Germany
Prior art keywords
proteins
nutrificial
diagnosis
cancer
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325382T
Other languages
English (en)
Inventor
Peter S Lu
Johannes Schweizer
Chamorro Somoza Diaz-Sarmiento
Michael P Belmares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arbor Vita Corp
Original Assignee
Arbor Vita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/630,590 external-priority patent/US7312041B2/en
Application filed by Arbor Vita Corp filed Critical Arbor Vita Corp
Application granted granted Critical
Publication of DE60325382D1 publication Critical patent/DE60325382D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60325382T 2002-09-09 2003-09-09 Verfahren zur diagnose von gebärmutterhalskrebs Expired - Lifetime DE60325382D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40929802P 2002-09-09 2002-09-09
US45046403P 2003-02-27 2003-02-27
US49009403P 2003-07-25 2003-07-25
US10/630,590 US7312041B2 (en) 2001-02-16 2003-07-29 Methods of diagnosing cervical cancer
PCT/US2003/028508 WO2004022006A2 (en) 2002-09-09 2003-09-09 Methods of diagnosing cervical cancer

Publications (1)

Publication Number Publication Date
DE60325382D1 true DE60325382D1 (de) 2009-01-29

Family

ID=40157709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325382T Expired - Lifetime DE60325382D1 (de) 2002-09-09 2003-09-09 Verfahren zur diagnose von gebärmutterhalskrebs

Country Status (9)

Country Link
EP (2) EP2026070A1 (de)
JP (1) JP4694840B2 (de)
CN (2) CN102023220A (de)
AT (1) ATE418072T1 (de)
AU (2) AU2003270548B2 (de)
BR (1) BR0314155A (de)
CA (1) CA2495449A1 (de)
DE (1) DE60325382D1 (de)
WO (1) WO2004022006A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
AU2003291558B2 (en) * 2001-08-03 2009-08-13 Arbor Vita Corporation Molecular interactions in neurons
CA2551560A1 (en) * 2003-12-23 2005-07-14 Arbor Vita Corporation Antibodies for oncogenic strains of hpv and methods of their use
AU2005326784B2 (en) * 2004-10-08 2012-03-15 Virxsys Corporation Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
US7595152B2 (en) * 2005-07-01 2009-09-29 Arbor Vita Corporation Detection of influenza virus
ATE549624T1 (de) * 2005-07-01 2012-03-15 Arbor Vita Corp Verfahren und zusammensetzungen zur diagnose und behandlung von grippe
EP1915621A2 (de) * 2005-07-01 2008-04-30 Arbor Vita Corporation Verfahren und zusammensetzungen zur diagnose und behandlung viraler und bakterieller infektionen
US8633160B2 (en) 2005-12-30 2014-01-21 Nono Inc. Small molecule inhibitors of PDZ interactions
CN101460636A (zh) 2006-05-11 2009-06-17 伯克顿迪金森公司 从细胞中提取蛋白质的方法
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
US20120141502A1 (en) * 2009-04-20 2012-06-07 Eric Dixon Antibodies specific to e6 proteins of hpv and use thereof
EP2581384A1 (de) * 2011-10-11 2013-04-17 Institut Pasteur Zur Behandlung maligner Neoplasmen des menschlichen Nervensystems nützliche Produkte
WO2015097268A1 (en) * 2013-12-23 2015-07-02 Universite De Strasbourg A chimeric construct for diagnosis and therapy of papillomavirus-induced cancers
KR101646746B1 (ko) * 2014-04-29 2016-08-09 고려대학교 산학협력단 자궁경부암의 유도에 관여하는 악티닌―４의 약제학적 용도
KR101693190B1 (ko) * 2015-01-28 2017-01-05 연세대학교 산학협력단 인유두종바이러스 검사와 mkrn1 발현 패턴에 따른 자궁경부암 예측 및 진단 방법
US20220026430A1 (en) * 2020-07-27 2022-01-27 Oncogenesis, Inc. Screening systems and methods for hpv-associated cervical disease

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4011350A (en) 1971-05-05 1977-03-08 Clinical Sciences, Inc. Method of making microscope slide system
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4108846A (en) 1977-02-01 1978-08-22 Hoffmann-La Roche Inc. Solid phase synthesis with base N alpha-protecting group cleavage
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
EP0111762B1 (de) * 1980-06-20 1987-11-19 Unilever Plc Verfahren und Gerät zur Durchführung spezifischer Bindungsbestimmungen
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4782137A (en) 1984-01-24 1988-11-01 Immunex Corporation Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same
US4703004A (en) 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US5876922A (en) 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
ES2039254T3 (es) 1986-03-21 1995-04-01 Pasteur Institut Secuencias determinadas de adn, derivadas de un genoma de papilomavirus, sus usos con finalidades de diagnostico in vitro y la produccion de composiciones antigenas.
US4777239A (en) 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
US5011912A (en) 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
US5204061A (en) * 1987-10-08 1993-04-20 Becton, Dickinson And Company Depositing a binder on a solid support
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
ES2118066T3 (es) 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5753233A (en) 1990-05-10 1998-05-19 Behring Diagnostics Gmbh Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18
DE4015044A1 (de) 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
FR2670797A1 (fr) 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
NZ243090A (en) 1991-06-18 1993-11-25 Lilly Co Eli Method of identifying active peptides and synthesis of peptide mixtures with a known amino acid in the last coupled position
ATE234860T1 (de) * 1991-07-13 2003-04-15 Dade Behring Marburg Gmbh Verwendung von hpv-16 e6 und e7-gen gewonnen peptiden für den diagnostischen zweck
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5569608A (en) 1995-01-30 1996-10-29 Bayer Corporation Quantitative detection of analytes on immunochromatographic strips
WO1997015494A1 (de) 1995-10-23 1997-05-01 Fleximation Ag Befüllung von pharmazeutischen mehrkammerverpackungen
US6403383B1 (en) 1996-03-11 2002-06-11 American Bio Medica Corp. Diagnostic test kit for immunological assays of fluid samples
DE69938293T2 (de) 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
WO1999053841A1 (en) 1998-04-23 1999-10-28 Cook Urological, Inc. Endocervical and exocervical cell collection device
US6336905B1 (en) 1998-10-30 2002-01-08 Rana A. Colaianni Endocervical sampling device
US6282965B1 (en) * 1998-11-20 2001-09-04 Emerson Electric Co. Method and apparatus for detecting washing machine tub imbalance
US6297020B1 (en) 1999-03-01 2001-10-02 Bayer Corporation Device for carrying out lateral-flow assays involving more than one analyte
JP2004535751A (ja) * 1999-04-14 2004-12-02 アルボー ビータ コーポレーション Ｃｌａｓｐ−２膜貫通タンパク質
EP1169449A2 (de) * 1999-04-14 2002-01-09 Arbor Vita Corporation Clasp-2 transmembranproteine
US6180417B1 (en) 1999-04-22 2001-01-30 Bayer Corporation Immunochromatographic assay
EP1235518A1 (de) 1999-06-25 2002-09-04 Ampersand Medical Corporation Kollektor für cervikale zellen zum eigengebrauch
US6440696B1 (en) * 1999-07-28 2002-08-27 New England Medical Center E6 targeted protein (E6TP1)
US6241687B1 (en) 2000-02-18 2001-06-05 Ethicon Endo-Surgery, Inc. Method of use for a biopsy instrument with breakable sample segments

Also Published As

Publication number Publication date
BR0314155A (pt) 2005-07-05
AU2008258186A1 (en) 2009-01-15
AU2003270548A1 (en) 2004-03-29
WO2004022006A3 (en) 2004-07-15
AU2003270548B2 (en) 2008-09-25
ATE418072T1 (de) 2009-01-15
CN1695058B (zh) 2011-04-13
JP4694840B2 (ja) 2011-06-08
EP1537415A4 (de) 2006-03-01
EP1537415B1 (de) 2008-12-17
JP2005538360A (ja) 2005-12-15
EP2026070A1 (de) 2009-02-18
CN102023220A (zh) 2011-04-20
CN1695058A (zh) 2005-11-09
CA2495449A1 (en) 2004-03-18
WO2004022006A2 (en) 2004-03-18
EP1537415A2 (de) 2005-06-08

Similar Documents

Publication Publication Date Title
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DE60320867D1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
EP1439393A3 (de) Nachweisverfahren TIMP 1 verwendend für Kolonkrebs-Diagnose
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
ATE420204T1 (de) Verfahren zur detektion von erkrankungen
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
EP1708745A4 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
WO2004029216A3 (en) Diagnosis of invasive mold infection
AU2490102A (en) Method for diagnosing a tumor in a patient determining the concentration of pibf
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
WO2004094989A3 (en) Methods of host cell protein analysis
EP1241269A3 (de) Verfahren zum Nachweiss von REG-ähnliches Protein und dafür kodierende Nukleinäuren
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Legal Events

Date Code Title Description
8364 No opposition during term of opposition